Sublingually administered bacterial lysates: rationale, mechanisms of action and clinical outcomes

被引:1
|
作者
Braido, Fulvio [1 ,2 ]
Melioli, Giovanni [3 ]
Nicolini, Gabriele [4 ]
Ferraris, Melissa [2 ]
Di Girolamo, Stefano [5 ]
Di Gioacchino, Mario [6 ,7 ]
Canonica, Giorgio Walter [8 ,9 ]
机构
[1] IRCCS Osped Policlin San Martino, Genoa, Italy
[2] Univ Genoa, DiMI, Genoa, Italy
[3] Alliance Med Diagnost, Genoa, Italy
[4] Bruschettini srl, Genoa, Italy
[5] Tor Vergata Sch Med & Surg, Otorhinolaryngol Dept Clin Sci & Translat Med, Rome, Italy
[6] Univ G dAnnunzio, Ctr Adv Studies & Technol, Chieti, Italy
[7] Inst Clin Immunotherapy & Adv Biol Treatments, Pescara, Italy
[8] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[9] IRCCS Humanitas Res Hosp, Asthma & Allergy Unit, Milan, Italy
关键词
bacterial lysate; immunological mecha-; nisms; sublingual administration; RESPIRATORY-TRACT INFECTIONS; ELDERLY-PATIENTS; ORAL ANTIGEN; DOUBLE-BLIND; COPD; MULTICENTER; PREVENTION; INDUCTION; EFFICIENT; IMMUNITY;
D O I
10.7573/dic.2024-1-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review discusses available evidence on the mechanisms of action of bacterial lysates, and the clinical effects of their sublingual administration. Bacterial lysates act through many immunological effects, including dendritic cell activation, modification of circulating lymphocyte subsets and antibody production. The production of salivary IgA was repeatedly shown to be induced by the sublingual administration of a prototype bacterial lysate containing soluble and corpuscular antigens. Bacterial lysates are a useful tool for the prevention of recurrent respiratory tract infections. Sublingual administration should be the preferred option.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Action mechanisms and efficacy of bacterial lysates
    Müschenborn, S
    Reinhardt, D
    MONATSSCHRIFT KINDERHEILKUNDE, 2000, 148 (01) : 54 - 54
  • [2] CLINICAL PHARMACOKINETICS OF DRUGS ADMINISTERED BUCCALLY AND SUBLINGUALLY
    MOTWANI, JG
    LIPWORTH, BJ
    CLINICAL PHARMACOKINETICS, 1991, 21 (02) : 83 - 94
  • [3] Clinical and bioavailability studies of sublingually administered atropine sulfate
    Rajpal, Sheetal
    Ali, Raisuddin
    Bhatnagar, Aseem
    Bhandari, Sujit Kumar
    Mittal, Gaurav
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (02): : 143 - 150
  • [5] ACTIVE SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH ALLOGENEIC CELL LYSATES - RATIONALE, RESULTS, AND POSSIBLE MECHANISMS OF ACTION
    MITCHELL, MS
    HAREL, W
    KANMITCHELL, J
    LEMAY, LG
    GOEDEGEBUURE, P
    HUANG, XQ
    HOFMAN, F
    GROSHEN, S
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 690 : 153 - 166
  • [6] TNF-ALPHA BLOCKADE IN RHEUMATOID-ARTHRITIS - RATIONALE, CLINICAL OUTCOMES AND MECHANISMS OF ACTION
    ELLIOTT, MJ
    FELDMANN, M
    MAINI, RN
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (02): : 141 - 145
  • [7] Preclinical rationale, mechanisms of action, and clinical activity of anthracyclines in myeloma
    Hussein, Mohamad A.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S145 - S149
  • [8] CLINICAL EFFECTS OF SUBLINGUALLY ADMINISTERED ROSUVASTATIN IN SUBJECTS WHO ARE STATIN INTOLERANT (SARSI)
    Szto, Gregory
    Kannar, David
    O'Shea, Vikki
    Madmon, Tomer
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1766 - 1766
  • [9] Inhibitors of bacterial topoisomerases: Mechanisms of action and resistance and clinical aspects
    Heisig, P
    PLANTA MEDICA, 2001, 67 (01) : 3 - 12
  • [10] PROTECTIVE EFFECTS OF ORALLY-ADMINISTERED, KLEBSIELLA-CONTAINING BACTERIAL LYSATES IN MICE
    KUENEN, JDM
    VANDIJKE, EEM
    HOL, C
    BOOTSMA, HJ
    VERHOEF, J
    VANDIJK, H
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1994, 8 (01): : 69 - 75